• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Bangalore , Sept. 14

The Karnataka Government on Thursday said it has banned an injection formulation made by a Himachal Pradesh-based contract manufacturer for Elder Pharma.

In an apparent case of mislabelling, the injection used against infections had the label of Mumbai-based Elder Pharma's Zoftariz (Ceftriaxone sodium). However, it did not contain that drug but had diclofenac sodium, an analgesic, the Health Minister, Mr R. Ashok, told a news conference.

Elder Pharma's brand of cephalosporin is used to treat meningitis and STDs. Health Biotech Ltd of Baddi in Himachal manufactured the drug for it.

The drugs controller, Mr M.N. Ramamurthy, said his counterparts in other States had been alerted and Himachal and Maharashtra requested to take action against the two companies. The batches had been traced, potential user agencies alerted and the department was taking action to seize it. Further investigation was on, he said.

The Government analyst's verdict on the "spurious" drug was that the seized sample was not of standard quality "with respect to description, presence of diclofenac sodium and absence of Ceftriaxone."

More Stories on : Policy | Standards & Benchmarks | Health | Pharmaceuticals | Karnataka

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Centre can nominate RBI official to ICAI

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line